Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-41061 in patients with hepatic edema due to cirrhosis
jRCT2080221078Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tolvaptan in hepatic edema, ascites and Cirrhosis (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
tolvaptan
03
Conditions
hepatic edemaascitesCirrhosis
Beyond the preview
Go deeper on jRCT2080221078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221078.